Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure

Journal of Cardiology

Volumn 63, Issue 3, 2014, Pages 182-188

  Hamaguchi, Sanae ^a,b   Kinugawa, Shintaro ^a   Tsuchihashi Makaya, Miyuki ^c   Matsushima, Shouji ^a   Sakakibara, Mamoru ^a   Ishimori, Naoki ^a   Goto, Daisuke ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Obihiro Hospital   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Heart failure; Hyponatremia; Outcomes; Prognosis; Sodium

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ATRIAL NATRIURETIC FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; ISOSORBIDE DINITRATE; LOOP DIURETIC AGENT; NITRATE; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR; SODIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT; WARFARIN;

AGED; ARTICLE; BLOOD SAMPLING; CARDIOVERSION; CAUSE OF DEATH; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DISEASE REGISTRY; DIURETIC THERAPY; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPONATREMIA; ISCHEMIC HEART DISEASE; LABORATORY TEST; LEFT VENTRICULAR ASSIST DEVICE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; RISK FACTOR; SODIUM BLOOD LEVEL; VALVULAR HEART DISEASE;

HEART FAILURE; HYPONATREMIA; OUTCOMES; PROGNOSIS; SODIUM;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FORECASTING; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; REGISTRIES; SODIUM; TIME FACTORS;

EID: 84896705483     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.07.012     Document Type: Article

References (30)

1. Klein L., O'Connor C.M., Leimberger J.D., Gattis-Stough W., Pina I.L., Felker G.M., Adams K.F., Califf R.M., Gheorghiade M. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 2005, 111:2454-2460.
2. Gheorghiade M., Abraham W.T., Albert N.M., Gattis Stough W., Greenberg B.H., O'Connor C.M., She L., Yancy C.W., Young J., Fonarow G.C. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007, 28:980-988.
3. Rusinaru D., Tribouilloy C., Berry C., Richards A.M., Whalley G.A., Earle N., Poppe K.K., Guazzi M., Macin S.M., Komajda M., Doughty R.N. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis: Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur J Heart Fail 2012, 14:1139-1146.
4. Gheorghiade M., Rossi J.S., Cotts W., Shin D.D., Hellkamp A.S., Pina I.L., Fonarow G.C., DeMarco T., Pauly D.F., Rogers J., DiSalvo T.G., Butler J., Hare J.M., Francis G.S., Stough W.G., et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007, 167:1998-2005.
5. Tsutsui H., Tsuchihashi-Makaya M., Kinugawa S., Goto D., Takeshita A. Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. Circ J 2006, 70:1617-1623.
6. Hamaguchi S., Tsuchihashi-Makaya M., Kinugawa S., Yokota T., Ide T., Takeshita A., Tsutsui H. Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009, 73:1442-1447.
7. Hamaguchi S., Yokoshiki H., Kinugawa S., Tsuchihashi-Makaya M., Yokota T., Takeshita A., Tsutsui H. Effects of atrial fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan: a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009, 73:2084-2090.
8. Tsuchihashi-Makaya M., Hamaguchi S., Kinugawa S., Yokota T., Goto D., Yokoshiki H., Kato N., Takeshita A., Tsutsui H. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009, 73:1893-1900.
9. Hamaguchi S., Kinugawa S., Tsuchihashi-Makaya M., Goto K., Goto D., Yokota T., Yamada S., Yokoshiki H., Takeshita A., Tsutsui H. Spironolactone use at discharge was associated with improved survival in hospitalized patients with systolic heart failure. Am Heart J 2010, 160:1156-1162.
10. Hamaguchi S., Furumoto T., Tsuchihashi-Makaya M., Goto K., Goto D., Yokota T., Kinugawa S., Yokoshiki H., Takeshita A., Tsutsui H. Hyperuricemia predicts adverse outcomes in patients with heart failure. Int J Cardiol 2011, 151:143-147.
11. Tsuchihashi-Makaya M., Hamaguchi S., Kinugawa S., Goto K., Goto D., Furumoto T., Yamada S., Yokoshiki H., Takeshita A., Tsutsui H. Sex differences with respect to clinical characteristics, treatment, and long-term outcomes in patients with heart failure. Int J Cardiol 2011, 150:338-339.
12. Hamaguchi S., Kinugawa S., Sobirin M.A., Goto D., Tsuchihashi-Makaya M., Yamada S., Yokoshiki H., Tsutsui H. Mode of death in patients with heart failure and reduced vs preserved ejection fraction: report from the registry of hospitalized heart failure patients. Circ J 2012, 76:1662-1669.
13. Goto D., Kinugawa S., Hamaguchi S., Sakakibara M., Tsuchihashi-Makaya M., Yokota T., Yamada S., Yokoshiki H., Tsutsui H. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan. J Cardiol 2013, 61:65-70.
14. Hamaguchi S., Kinugawa S., Tsuchihashi-Makaya M., Goto D., Tsutsui H. Weekend versus weekday hospital admission and outcomes during hospitalization for patients due to worsening heart failure: a report from Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Heart Vessels 2013, (May). [Epub ahead of print].
15. Hamaguchi S., Kinugawa S., Tsuchihashi-Makaya M., Goto D., Yamada S., Yokoshiki H., Tsutsui H. Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure - a report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). J Cardiol 2013, 62:95-101.
16. Oliva F., Mortara A., Cacciatore G., Chinaglia A., Di Lenarda A., Gorini M., Metra M., Senni M., Maggioni A.P., Tavazzi L. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail 2012, 14:1208-1217.
17. Tokmakova M.P., Skali H., Kenchaiah S., Braunwald E., Rouleau J.L., Packer M., Chertow G.M., Moye L.A., Pfeffer M.A., Solomon S.D. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation 2004, 110:3667-3673.
18. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., Krumholz H.M. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006, 47:1987-1996.
19. Heywood J.T., Fonarow G.C., Costanzo M.R., Mathur V.S., Wigneswaran J.R., Wynne J. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007, 13:422-430.
20. Francis G.S. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 1989, 118:642-648.
21. Triposkiadis F., Karayannis G., Giamouzis G., Skoularigis J., Louridas G., Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009, 54:1747-1762.
22. Sica D.A. Hyponatremia and heart failure - pathophysiology and implications. Congest Heart Fail 2005, 11:274-277.
23. Jao G.T., Chiong J.R. Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options. Clin Cardiol 2010, 33:666-671.
24. Bettari L., Fiuzat M., Felker G.M., O'Connor C.M. Significance of hyponatremia in heart failure. Heart Fail Rev 2012, 17:17-26.
25. Goldsmith S.R., Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol 2005, 46:1785-1791.
26. Cooper H.A., Dries D.L., Davis C.E., Shen Y.L., Domanski M.J. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999, 100:1311-1315.
27. Hasselblad V., Gattis Stough W., Shah M.R., Lokhnygina Y., O'Connor C.M., Califf R.M., Adams K.F. Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 2007, 9:1064-1069.
28. Hamaguchi S., Kinugawa S., Tsuchihashi-Makaya M., Goto D., Yamada S., Yokoshiki H., Takeshita A., Tsutsui H. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 2012, 76:1920-1927.
29. Konstam M.A., Gheorghiade M., Burnett J.C., Grinfeld L., Maggioni A.P., Swedberg K., Udelson J.E., Zannad F., Cook T., Ouyang J., Zimmer C., Orlandi C. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297:1319-1331.
30. Hauptman P.J., Burnett J., Gheorghiade M., Grinfeld L., Konstam M.A., Kostic D., Krasa H.B., Maggioni A., Ouyang J., Swedberg K., Zannad F., Zimmer C., Udelson J.E. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail 2013, 19:390-397.